HOME >> MEDICINE >> NEWS
From smoking to sumatriptan, researchers present important new findings on the impacts of drug metabolism

LOS ANGELES -- Pharmacologists from across the country and around the world will offer more than 350 presentations during the American Society for Clinical Pharmacology and Therapeutics annual meeting March 15-18 at the Century Plaza Hotel & Tower. They include:

Why do Chinese-Americans smoke less than whites?

It's one of the major curiosities in smoking behavior -- why one smoker is content with one or two cigarettes a day but another craves a pack a day or more. New research from Rachel Tyndale, MD, and her colleagues at the University of Toronto indicates that people with defects in the CYP2A6 gene tend to smoke about one-third fewer cigarettes per day than people without the defects. People with CYP2A6 defects metabolize nicotine slower, so they don't smoke as much. Neal Benowitz, MD, and colleagues at the University of California at San Francisco report that slow metabolism of nicotine due to CYP2A6 defects may explain why Chinese-Americans smoke less than whites. (Oral presentations)

Sweet News for Sickle Cell Anemia Sufferers

The artificial sweetener aspartame has been reported to be effective in counteracting the effects of abnormal hemoglobin that reduce oxygen in red blood cells, causing sickle cell anemia. However, appropriate doses for clinical use have not been determined. In a new study of 24 patients, researchers from Oklahoma Medical Research Foundation and Oklahoma University Health Sciences Center have determined an amount that remains effective for eight hours or longer. The findings are good news for sickle cell anemia patients, as few treatment drugs are available. (Poster PI-55).

Quick Relief for Adolescents with Migraine

Adults plagued by migraine headache have been able to obtain quick relief with a nasal spray of the drug sumatriptan since 1997. But that doesn't help the 8 million children and adolescents who suffer from migraines since clinicians have been uncertain about amounts
'"/>

Contact: Kirk Monroe
kmcpr@aol.com
202-789-8101
K-M Communications
14-Mar-2000


Page: 1 2

Related medicine news :

1. NHS stop-smoking services are insufficient to deliver national smoking targets
2. Study suggests smoking while pregnant may increase chromosomal abnormalities in fetal cells
3. Current daily smoking may be associated with increased risk for suicidal thoughts and attempts
4. School-based smoking prevention programs ineffective
5. Parents who quit smoking may influence their offspring to quit as young adults
6. Inpatient smoking cessation counseling is associated with early differences in mortality
7. NHLBI study shows smoking cessation programs improve survival
8. 14-year study finds that quitting smoking adds years to life
9. Campus can be effective site for anti-smoking efforts
10. Contrary to previous findings, smoking is detrimental to patients with Alzheimers
11. State policies decrease youth smoking, drinking and sex

Post Your Comments:
(Date:10/22/2014)... (PRWEB) October 22, 2014 Healthcare ... completing their continuing education at home or on-the-go ... access to 20 brand new, premium Seminar-on-Demand CE ... catalog of over 2,000 hours of ... customize their educational experience. With such a diverse ...
(Date:10/22/2014)... Lintelus, Inc., an event software provider, announced ... will be speaking on the subject of “Event Technology ... 28, at the Holiday Inn in New York City. ... as a Tech Demo at 12:45pm, to educate event ... engaging event experience. , The Annual Meetings Technology Expo ...
(Date:10/22/2014)... HealthDay Reporter , TUESDAY, Oct. 21, 2014 (HealthDay ... be showing a genetic propensity for obesity as toddlers, a ... linked to increased body fat, but the same genes in ... researchers said. At 1 year, kids with these genes ... however, these genes were linked to excessive weight gain, the ...
(Date:10/22/2014)... Tara Haelle HealthDay Reporter ... among young adult men may lead to increased blood pressure, ... cause a similar rise in blood pressure for young adult ... when young adult women drank lightly or moderately, their risk ... found. "This finding parallels studies in older adult men ...
(Date:10/22/2014)... Thompson HealthDay Reporter , MONDAY, ... Monday officially tightened guidelines for health workers treating Ebola patients, ... use of a respirator at all times. The U.S. ... tougher rules after two Dallas nurses contracted Ebola while caring ... Liberian national Thomas Eric Duncan. Nina Pham is currently being ...
Breaking Medicine News(10 mins):Health News:Top Provider of Continuing Education at Home Releases 20 New Online Courses 2Health News:Jay Cormier, Sr. Vice President of Sales for Lintelus, Speaks about Event Technology Integration at Meetings Technology Expo in NYC 2Health News:Tall, Heavy 1-Year-Olds May Be at Risk for Obesity Later, Study Finds 2Health News:Binge Drinking May Boost Blood Pressure in Young Men 2Health News:Binge Drinking May Boost Blood Pressure in Young Men 3Health News:Binge Drinking May Boost Blood Pressure in Young Men 4Health News:CDC Tightens Rules on Caring for Ebola Patients 2Health News:CDC Tightens Rules on Caring for Ebola Patients 3
(Date:10/22/2014)... , Oct. 22, 2014  AcelRx Pharmaceuticals, Inc. ... results from the  IAP310 study have been published ... a peer-reviewed journal with broad, multidisciplinary readership. ... evaluating the safety and efficacy of Zalviso, also ... (SSTS), for the treatment of post-operative pain in ...
(Date:10/22/2014)... , Oct. 22, 2014  Regulus Therapeutics ... biopharmaceutical company leading the discovery and development ... that it has demonstrated human proof-of-concept with ... study evaluating RG-101, a wholly-owned, GalNac-conjugated anti-miR ... hepatitis C virus infection ("HCV").  Interim results ...
(Date:10/20/2014)... , Oct. 20, 2014  PneumRx, Inc. ( www.pneumrx.com ... today announced completion of enrollment in their RENEW Study, ... Study is the FDA-approved IDE pivotal trial for the ... It was anticipated that the study, which ... would take until the end of 2014 to enroll ...
Breaking Medicine Technology:AcelRx Announces Publication of Zalviso Phase 3 Abdominal Trial Results 2A Single Subcutaneous Dose of 2mg/kg of RG-101, Regulus' Wholly-Owned, GalNac-Conjugated anti-miR Targeting microRNA-122, Demonstrates 4.1 log10 Mean Viral Load Reduction as Monotherapy at Day 29 in Patients with Varied HCV Genotypes and Treatment H 2A Single Subcutaneous Dose of 2mg/kg of RG-101, Regulus' Wholly-Owned, GalNac-Conjugated anti-miR Targeting microRNA-122, Demonstrates 4.1 log10 Mean Viral Load Reduction as Monotherapy at Day 29 in Patients with Varied HCV Genotypes and Treatment H 3A Single Subcutaneous Dose of 2mg/kg of RG-101, Regulus' Wholly-Owned, GalNac-Conjugated anti-miR Targeting microRNA-122, Demonstrates 4.1 log10 Mean Viral Load Reduction as Monotherapy at Day 29 in Patients with Varied HCV Genotypes and Treatment H 4A Single Subcutaneous Dose of 2mg/kg of RG-101, Regulus' Wholly-Owned, GalNac-Conjugated anti-miR Targeting microRNA-122, Demonstrates 4.1 log10 Mean Viral Load Reduction as Monotherapy at Day 29 in Patients with Varied HCV Genotypes and Treatment H 5A Single Subcutaneous Dose of 2mg/kg of RG-101, Regulus' Wholly-Owned, GalNac-Conjugated anti-miR Targeting microRNA-122, Demonstrates 4.1 log10 Mean Viral Load Reduction as Monotherapy at Day 29 in Patients with Varied HCV Genotypes and Treatment H 6A Single Subcutaneous Dose of 2mg/kg of RG-101, Regulus' Wholly-Owned, GalNac-Conjugated anti-miR Targeting microRNA-122, Demonstrates 4.1 log10 Mean Viral Load Reduction as Monotherapy at Day 29 in Patients with Varied HCV Genotypes and Treatment H 7A Single Subcutaneous Dose of 2mg/kg of RG-101, Regulus' Wholly-Owned, GalNac-Conjugated anti-miR Targeting microRNA-122, Demonstrates 4.1 log10 Mean Viral Load Reduction as Monotherapy at Day 29 in Patients with Varied HCV Genotypes and Treatment H 8PneumRx Completes RENEW Pivotal Trial Enrollment 2PneumRx Completes RENEW Pivotal Trial Enrollment 3
Cached News: